It might seem ridiculous to consider buying a stock that's run up 200% since the beginning of 2012 and now trades hands at 1,330 times earnings. But this month, LinkedIn (NYSE: LNKD ) is on the short list of stocks I'm considering to add to my Roth IRA.
I've been calling out one company per month for almost two years now, and the portfolio has returned 21%, beating the S&P 500 by almost 5 percentage points!
Here are three big reasons why I think investing in the company is a good idea right now:
1. The network effect is very powerful here
For those who might not be familiar, the network effect works like this: every time a user joins a service, the value of that service increases. The clearest example of this today would be Facebook (NASDAQ: FB ) . It wouldn't be worth joining Facebook if no one else was. But because there are over 500 million users, it's the "It" place to meet with others online.
The same thing is happening with LinkedIn. There are two sides to the equation: individual users joining LinkedIn and posting their resumes, and businesses signing up with LinkedIn to recruit potential hires. Take a look at how the two have been growing over time.
Best Promising Companies To Invest In Right Now: Balfour Beatty PLC (BIH)
Balfour Beatty plc is a global infrastructure company that delivers services essential to the development, creation and care of infrastructure assets; from finance and development, through design and project management to construction and maintenance. The Company operates in four segments: Professional Services segment is engaged in the provision of project management; Construction Services segment is engaged in the activities resulting in the physical construction of an asset; Support Services segment is engaged in the activities, which support existing assets or functions, and Infrastructure Investments segment is engaged in the acquisition, operation and disposal of infrastructure assets, such as PPP concessions and airports. In July 2013, it announced the disposal of its 50% interest in the Salford Hospital PFI asset. In December 2013, Balfour Beatty Plc completed the sale of its UK facilities management business to GDF Suez Energy Services. Advisors' Opinion:- [By Vanina Egea]
A few companies excel over their market peers, granting them an unconventional competitive advantage. Everybody knows the market leaders, or the mammoth companies, but there are other particular services that can give a firm greater exposure. No other example is more relevant than the rotary rig count offered by Baker Hughes (BIH). The Baker Hughes Rig Counts provides a weekly count of U.S. and Canadian drilling activity to the industry since 1944, and has become an important business barometer for the drilling industry and its suppliers. Most importantly, the index allows industry analysts to identify industry trends, while providing valuable information to prospect investors beyond Baker Hughes itself. After experiencing a decline in performance from mid-2011 to the end of 2012, the company saw great improvement in overall performance during 2013. Can the trend be expected to continue?
Top 5 Net Payout Yield Companies To Buy For 2014: CryoLife Inc (CRY)
CryoLife, Inc. (CryoLife,), incorporated in January 19,1984, is a biological medical device company. The Company preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve (CryoValve SGPV) and the CryoPatch SG pulmonary cardiac patch tissue (CryoPatch SG), both processed using CryoLife�� SynerGraft technology. The Company operates in two segments: preservation services and medical devices segment. The preservation services segment includes services revenues from the preservation of cardiac and vascular tissues during the year ended December 31, 2011. The medical devices segment includes revenues from product sales of BioGlue, BioFoam, PerClot, HemoStase and revascularization technologies, as well as sales of other medical devices. CryoLife�� surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam) and PerClot, an absorbable powdered hemostat. In May 2011, it acquired Cardiogenesis Corporation. In May 2012, the Company acquired Hemosphere, Inc. Hemosphere develops and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction. In February 2014, CryoLife Inc announced the establishment of CryoLife Asia Pacific Pte. Ltd.
CryoLife distributes preserved human cardiac and vascular tissues to implanting institutions throughout the United States (U.S), Canada and Europe. CryoLife processes and preserves cardiac and vascular tissues using processing and freezing techniques, or cryopreservation. The Company�� preservation process involves the recovery of tissue from deceased human donors by tissue banks and organ procurement organizations (OTPOs), the delivery, of such tissue to the Company, the s! creening, dissection, disinfection, processing, and preservation of the tissue by the Company, and the storage and shipment of the preserved tissue.
The human heart valves and cardiac patch tissues preserved by the Company are used in cardiac reconstruction and heart valve replacement surgeries. The Company preserves human aortic and pulmonary heart valves for implantation by cardiac surgeons. In addition, the Company preserves human cardiac patches for surgeons. The Company preserves human cardiac patches in three primarily anatomic configurations: pulmonary hemi-artery, pulmonary trunk and pulmonary branch. As of December 31, 2011, CryoLife shipped approximately 77,600 heart valves and cardiac patch tissues, including approximately 3,000 shipments during 2011.
The human vascular tissues preserved by the Company, including the CryoVein and CryoArtery, are used to treat a variety of vascular reconstructions, such as peripheral bypass, hemodialysis access and aortic infections. The Company preserves small diameter human saphenous vein conduits (3 millimeter to 6 millimeter) for use in peripheral vascular reconstructions. The Company also preserves femoral veins and arteries and aortoiliac arteries for bypass, hemodialysis access, or reconstruction within infected surgical areas. As of December 31, 2011, the Company shipped approximately 66,100 human vascular tissues, including approximately 4,500 shipments during 2011.
CryoLife�� product BioGlue, designed for cardiac, vascular, pulmonary, and general surgical applications, is a polymer based on bovine blood protein and an agent for cross-linking proteins. CryoLife distributes BioGlue throughout the United States and approximately 75 other countries. CryoLife distributes BioGlue for repair of soft tissues under conformite Europeene Mark Product Certification (CE Mark). CryoLife distributes BioGlue in Japan for use in the repair of aortic dissections.
CryoLife�� product, BioFoam, is a protein hydr! ogel biom! aterial with an expansion agent, which generates a mixed-cell foam. The foam creates a mechanical barrier to decrease blood flow and develops pores for the blood to enter, leading to cellular aggregation and enhanced hemostasis. CryoLife distributes BioFoam under CE Mark certification.
CryoLife�� product, PerClot, is an absorbable, powdered hemostatic agent used in surgery. PerClot particles have a molecular structure that absorbs water from blood, creating a high concentration of platelets, red blood cells, and coagulation proteins at the bleeding site, which accelerates the physiologic clotting cascade. PerClot is readily dissolved by saline irrigation and is totally absorbed within several days. PerClot is available in one gram, three gram and five gram sizes with a 100 millimeter or 200 millimeter applicator tip. PerClot Laparoscopic is available in one gram and three gram sizes with a 380 millimeter applicator tip.
The Company competes with St. Jude Medical, Inc., Medtronic, Inc., Edwards Life Sciences, Inc., Neovasc, Inc., LifeNet Health, Inc. W.L. Gore & Associates��Propaten, C.R. Bard, Inc., Hancock Jaffe Laboratories, Inc., Maquet, Inc., CorMatrix Cardiovascular, Inc., Baxter International, Inc., Johnson & Johnson Company, Covidien Ltd, NeoMend, Inc., Pfizer, Inc., Orthovita, Inc., King Pharmaceuticals, Inc., Ethicon, Inc., ZymoGenetics, Inc. and Nycomed.
Advisors' Opinion:- [By Eric Volkman]
CryoLife (NYSE: CRY ) is putting some zip into its shares with a dividend boost. The company has declared a fresh quarterly distribution of $0.0275 per share, to be paid on June 21 to shareholders of record as of June 14. This marks the company's first-ever dividend increase -- the new amount is 10% higher than its three prior (and only) payouts, each of which totaled $0.025.
Top 5 Net Payout Yield Companies To Buy For 2014: GOFF, CORP. (GOFF)
Goff Corporation, incorporated on July 12, 2010, is a development-stage company. The Company, through its wholly owned subsidiary, Golden Glory Resources S.A., is engaged in mineral exploration. The Company's primary project is the La Frontera Gold Project located in the Aguadas Department, in Caldas, Colombia. The Project is being pursued as a potential bulk-tonnage, gold-silver target. Golden Glory acquired its leases on the La Frontera through a transaction with a Colombian company and holds a 100% working interest in the property. The Company through its subsidiary Golden Glory Resources, focuses on the La Frontera Gold Project covers prospective ground and merits continued gold exploration, including exploration diamond drilling. In April 2013, the Company has established a new, wholly owned subsidiary Golden Glory Resources Colombia SAS.
The La Frontera Project is in the Aguadas, Department Of Caldera, which is located approximately 60 kilometers south of Medellin, Colombia. A NI43-101 report is completed on the La Frontera Property, which identifies the potential for gold in both veins and a porphyry structure on the leases. The LGC-15011 Project (La Frontera Project) is located in the northern department of Caldas, Colombia (LGC-15011 has 30% in Antioquia), in the village of Puente Piedra, in the municipality of Aguadas.
Advisors' Opinion:- [By Brian Richards]
Goff (NASDAQOTCBB: GOFF ) , a social recruiting-company-turned-Colombian-gold miner, did not exist as an incorporated business before the summer of 2010 and did not trade as a public company until March 2013. Yet since its debut on the over-the-counter market, on average it has traded more shares each day than Apple or ExxonMobil.
Top 5 Net Payout Yield Companies To Buy For 2014: Mid-America Apartment Communities Inc (MAA)
Mid-America Apartment Communities, Inc., incorporated on September 22, 1993, is a self-administered and self-managed real estate investment trust (REIT). The Company focuses on acquiring, owning and operating apartment communities in the Sunbelt region of the United States. The Company�� segments include Large market same store communities , Secondary market same store communities and Non same store communities and other . As of December 31, 2012 , the Company owned 100% of 160 properties representing 47,809 apartment units. Four properties include retail components with approximately 108,000 square feet of gross leasable area.
As of December 31, 2012 , the Company also had 33.33% ownership interests in Mid-America Multifamily Fund I, LLC, or Fund I, and Mid-America Multifamily Fund II, LLC, or Fund II, which owned two properties containing 626 apartment units and four properties containing 1,156 apartment units, respectively. These apartment communities were located across 13 states. In October 2013, Mid-America Apartment Communities Inc merged with Colonial Properties Trust. In October 2013, Mid America Apartment Communities Inc and Colonial Properties Trust announced the completion of the merger of the two companies.
The Company�� Large market same store communities are generally communities in markets with a population of at least one million and at least 1% of the total public multifamily REIT units that the Company has owned and that has been stabilized for at least a full 12 months and have not been classified as held for sale. Communities are considered stabilized after achieving and maintaining at least 90% occupancy for 90 days. Secondary market same store communities are generally communities in markets with populations of more than one million but less than 1% of the total public multifamily REIT units or markets with populations of less than one million that the Company has owned and that has been stabilized for at least a full 12 months and have not been cl! assified as held for sale. Communities are considered stabilized after achieving and maintaining at least 90% occupancy for 90 days. Non same store communities and other includes recent acquisitions, communities in development or lease-up and communities that have been classified as held for sale. Also included in non same store communities are non multifamily activities which represent less than 1% of the Company's portfolio.
The Company's business is conducted principally through Mid-America Apartments, L.P., which the Company refers to as its Operating Partnership. As of December 31, 2012 , the Company owned or had an ownership interest in 166 multifamily apartment communities in 13 different states. The Company also provides its own in-house leadership development program, which consists of a three-module program followed by two comprehensive case studies, which was developed with the assistance of U.S. Learning, Inc. During the year ended December 31, 2012, the Company purchased 10.6 acres of land and began construction on a new 270-unit community located in the Charleston, South Carolina metropolitan area. As of December 31, 2012 , no units have been delivered for the land in Charleston, South Carolina. During 2012, the Company also purchased 2.0 acres of land and began construction on a new 294-unit community located in Jacksonville, Florida.
Advisors' Opinion:- [By Marc Bastow]
Apartment community property real estate investment trust Mid-America Apartment Communities (MAA) raised its quarterly dividend 5% to 73 cents per share, payable on Jan. 31 to shareholders of record as of Jan. 15.
MAA Dividend Yield: 4.69%
No comments:
Post a Comment